To assess the prevalence of antibodies to hepatitis A virus (anti-HAV) in future travellers, all visitors to the Zurich University Vaccination Center in July/August 1990 were invited to participate in a cross-sectional study. A total of 1126 future travellers were recruited to have a blood sample dr
Prevalence of hepatitis A antibodies in schoolchildren in Catalonia (Spain) after the introduction of universal hepatitis A immunization
✍ Scribed by Àngela Domínguez; Miquel Bruguera; Pere Plans; Josep Costa; Lluís Salleras
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 66 KB
- Volume
- 73
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The objective of this study was to investigate the prevalence of hepatitis A antibodies (anti‐HAV) in schoolchildren in Catalonia and to compare it with the rates found in previous studies. Sera from a representative sample of 1,342 children aged between 6 and 15 years, recruited in 2001, were tested for anti‐HAV. The results were related to sociodemographic variables and vaccination history. The overall prevalence of anti‐HAV was 51.4%. The prevalence was 5.5% in non‐vaccinated children, similar to that found in a 1996 study, and 96.6% in vaccinated children. The prevalence of anti‐HAV in non‐vaccinated children increased significantly with age, reaching 11.6% in the 13–15 years age group. The prevalence of anti‐HAV was higher in children born outside Catalonia than in those born in Catalonia (16.1% vs. 5.0%, P = 0.02). The expected continuation in the decline in the prevalence of anti‐HAV in non‐vaccinated schoolchildren, observed in Catalonia since 1986, was not found in 2001. The rate of anti‐HAV in 2001 was slightly higher than in 1996, although the difference was not statistically significant (5.5 and 3.5%, respectively). This could be explained by the increased number of recent immigrant children born outside Catalonia, mainly in countries where hepatitis A is highly endemic. J. Med. Virol. 73:172–176, 2004. © 2004 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
Hepatitis A antibodies (anti-HAV) were surveyed in 1000 French recruits during 1990. The prevalence of anti-HAV in this group was 21.35%. Compared to a 1985 survey a 9% fall in the anti-HAV prevalence rate was observed. Living in a coastal area, low educational level, stay overseas were the main ris
Israel, located in a region endemic for hepatitis A virus (HAW, recently absorbed a large population of immigrants who came from the former USSR. To assess the risk of high morbidity in this population a serosurvey of HAV antibodies was undertaken. Serum samples were collected from 965 new immigrant
## Abstract Several studies had been carried out on anti‐hepatitis C virus (HCV) prevalence in populations with blood exposure risks and in blood donors. New tests are now available which allow the in‐ vestigation to extend to other parameters such as antibody type and HCV‐RNA. In this study the p
## Abstract Hepatitis E virus (HEV) is an infectious agent causing hepatitis among humans. Although hepatitis E has been reported from many European countries, its incidence in Europe is largely unknown, and the prevalence of the HEV infection is also unknown for most countries of the region. Antib
A seroepidemiological study of hepatitis E virus (HEV) infection was conducted in a district of Havana, where hepatitis A virus (HAV) is considered endemic. The levels of anti-HEV antibodies were evaluated by enzyme-linked immunosorbent assay (ELISA) based on the recombinant protein GST-ORF2.1. Anti